6-Amino-5-bromoquinoxaline
- CAS No.50358-63-9
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High-purity 6-Amino-5-bromoquinoxaline intermediate for pharmaceutical synthesis, ensuring reliable quality for Brimonidine production.
Request Bulk PricingProduct Technical Details
Product Overview
6-Amino-5-bromoquinoxaline is a specialized heterocyclic compound serving as a critical building block in modern medicinal chemistry. Characterized by its quinoxaline scaffold substituted with amino and bromo functional groups, this chemical entity plays a pivotal role in the synthesis of advanced pharmaceutical agents. Our facility produces this intermediate under strict quality control protocols to ensure consistency and reliability for downstream manufacturing processes.
As a key precursor, this compound is primarily utilized in the production of Brimonidine tartrate, a well-known therapeutic agent used in ophthalmology. The structural integrity and purity of the starting material directly influence the efficacy and safety of the final drug product. Therefore, sourcing high-quality 6-Amino-5-bromoquinoxaline is essential for pharmaceutical manufacturers aiming to meet regulatory standards and production efficiency goals.
Technical Specifications
We adhere to rigorous analytical standards to guarantee that every batch meets or exceeds industry requirements. The following table outlines the key physical and chemical parameters verified through our quality assurance laboratory.
| Parameter | Specification |
|---|---|
| CAS Number | 50358-63-9 |
| Molecular Formula | C8H6BrN3 |
| Molecular Weight | 224.057 g/mol |
| Appearance | Light yellow to brown powder |
| Assay (HPLC) | ≥99.0% |
| Loss on Drying | ≤0.5% |
| Melting Point | 151-153°C |
| Density | 1.7±0.1 g/cm3 |
Industrial Applications
The primary application of 6-Amino-5-bromoquinoxaline lies within the pharmaceutical sector, specifically as an intermediate for alpha-2 adrenergic agonists. Its chemical reactivity allows for precise functionalization during multi-step synthesis routes. Beyond ophthalmic solutions, quinoxaline derivatives are increasingly explored in various therapeutic areas including oncology and infectious disease research, making this compound a versatile asset for R&D departments.
Our manufacturing process optimizes yield while minimizing impurities, ensuring that the material is suitable for large-scale commercial production. We support clients with technical data packages that facilitate regulatory filings and process validation.
Quality Assurance and Storage
Quality is the cornerstone of our operation. Each production batch undergoes comprehensive testing using high-performance liquid chromatography and other analytical methods to confirm identity and purity. A Certificate of Analysis (COA) is provided with every shipment to document compliance with specified standards.
To maintain stability, the product should be stored in a cool, ventilated environment away from direct sunlight and moisture. Proper storage conditions prevent degradation and ensure the material remains within specification until use. We recommend following standard safety handling procedures appropriate for fine chemical intermediates.
Packaging and Logistics
We offer flexible packaging solutions to accommodate diverse supply chain needs. The standard packaging configuration is 25 kg per drum, which ensures safe transport and easy handling in industrial settings. Custom packaging options are available upon request to align with specific customer requirements.
As a global manufacturer, we maintain a robust logistics network to deliver products promptly to clients worldwide. Our commitment extends beyond supply to include ongoing technical support and partnership in your chemical synthesis projects. Contact our sales team for detailed information regarding bulk pricing, lead times, and sample availability.
